Leading swine veterinarians address overall vaccination compliance issues critical to effectively managing Mycoplasma hyopneumoniae and porcine circovirus in the latest At the Meeting (ATM) programme, produced by Dr Bob Morrison, University of Minnesota.
CHINA & GERMANY
Research driven pharmaceutical company Boehringer Ingelheim, in partnership with Taizhou China Medical City in Jiangsu Province, China, held a ground-breaking ceremony for a veterinary vaccine manufacturing plant at the China Medical City (Taizhou China Medicine High-Tech Development Zone) last week (Friday, 16 August).
US - Controlling swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCV2) and Mycoplasma pneumonia (M. hyo) is one of the the key challenges for producers and veterinarians. During the 2012 World Pork Expo, swine experts discussed the impacts of these diseases, the latest research and effective ways to manage respiratory diseases on modern production farms.
US - The research driven pharmaceutical company Boehringer Ingelheim will expand its global animal health vaccines business. With the completion of a series of major investments at the US site in St. Joseph, Missouri, the company will further enhance its position in the development and supply of vaccines against the most important diseases of pigs.
BARCELONA, SPAIN - An important anniversary in the history of porcine circovirus type 2 (PCV2) has been marked at a special international pig veterinary satellite symposium held in Barcelona, Spain in June 2011 as part of the 6th International Symposium on Emerging and Re-emerging Pig Diseases.
Read and download the posters.
The Committee for Medicinal Products for Veterinary Use (CVMP) has recommended to approve FLEXcombo®, the combined use of the veterinary medicinal products Ingelvac CircoFLEX® and Ingelvac MycoFLEX®, in the European Union.
Get the latest news on Swine Health Subscribe to our newsletter